Vanessa Peruhype-Magalhaes
Overview
Explore the profile of Vanessa Peruhype-Magalhaes including associated specialties, affiliations and a list of published articles.
Author names and details appear as published. Due to indexing inconsistencies, multiple individuals may share a name, and a single author may have variations. MedLuna displays this data as publicly available, without modification or verification
Snapshot
Snapshot
Articles
79
Citations
518
Followers
0
Related Specialties
Related Specialties
Top 10 Co-Authors
Top 10 Co-Authors
Published In
Published In
Affiliations
Affiliations
Soon will be listed here.
Recent Articles
1.
Sartori N, Machado K, Miyamoto S, Pretti F, Gouveia M, de Oliveira Y, et al.
Vaccines (Basel)
. 2025 Feb;
13(2).
PMID: 40006674
Objective: To evaluate the humoral response to and impact of SARS-CoV-2 vaccination in patients with systemic lupus erythematosus in a multicenter cohort design. Methods: Data for this analysis were obtained...
2.
Sasaki L, Canellas-de-Castro M, Fernandes G, Motta F, Araujo Junior D, de Araujo Junior D, et al.
Immunol Lett
. 2025 Feb;
274:106979.
PMID: 39933603
The present study intended to characterize the profile of soluble immune mediators in serum samples and in the cerebrospinal fluid (CSF) microenvironment from parturients with acute and convalescent COVID-19 as...
3.
Teixeira C, Dias J, Morgado-Santos L, da Costa-Rocha I, Giarola-Silva S, Lopes-Ribeiro A, et al.
Inflamm Res
. 2025 Jan;
74(1):16.
PMID: 39797999
Introduction: The present study aimed at evaluating the systemic profile and network connectivity of immune mediators during acute chikungunya fever (CHIKF) according to days of symptoms onset and ageing. Methods:...
4.
de Oliveira G, Costa-Rocha I, Oliveira-Carvalho N, Dos Santos T, Campi-Azevedo A, Peruhype-Magalhaes V, et al.
Microorganisms
. 2024 Nov;
12(11).
PMID: 39597661
The present study aimed to evaluate the kinetics of the phenotypic profile and integrative networks of T/B-cells in severe COVID-19 patients, categorized according to disease outcome, during the circulation of...
5.
Ribeiro J, Teixeira E, Alves L, Alves E, Pascoal-Xavier M, Santi A, et al.
Antimicrob Agents Chemother
. 2024 Oct;
68(11):e0075624.
PMID: 39387580
Visceral leishmaniasis, caused by in New World countries, is the most serious and potentially fatal form of leishmaniasis, if left untreated. There are currently no effective prophylactic measures, and therapeutic...
6.
Borges-Fernandes L, de Lima Moreira M, Pereira V, Pascoal-Xavier M, Lopes Ribeiro A, da Costa-Rocha I, et al.
Front Immunol
. 2024 Aug;
15:1373498.
PMID: 39192975
Introduction: Visceral leishmaniasis (VL) is an important tropical and neglected disease and represents a serious global health problem. The initial interaction between the phagocytes and the parasite is crucial to...
7.
Cruz V, Guimaraes C, Rego J, Machado K, Miyamoto S, Burian A, et al.
Adv Rheumatol
. 2024 Aug;
64(1):58.
PMID: 39135131
Background: Patients with immune-mediated rheumatic diseases (IMRDs) have been prioritized for COVID-19 vaccination to mitigate the infection severity risks. Patients with rheumatoid arthritis (RA) are at a high risk of...
8.
Santos F, Catao C, Martins J, Pessoa U, Sousa I, Melo J, et al.
PLoS One
. 2024 Jul;
19(7):e0298710.
PMID: 38968331
The present study compares the ability of distinct immunological assays (chemiluminescence immunoassay-CLIA, western blot-WB and flow cytometry-FC-Simplex and Duplex) to detect anti-HTLV (human T-lymphotropic virus) antibodies in candidates for blood...
9.
Machado K, da Costa-Rocha I, Aguiar L, Moulaz I, Miyamoto S, Costa Martins P, et al.
Hum Vaccin Immunother
. 2024 Jul;
20(1):2318814.
PMID: 38961639
The present study aimed at investigating whether the hydroxychloroquine (HCQ) treatment would impact the neutralizing antibody production, viremia levels and the kinetics of serum soluble mediators upon planned 17DD-Yellow Fever...
10.
Reis L, Costa-Rocha I, Abdala-Torres T, Campi-Azevedo A, Peruhype-Magalhaes V, Araujo M, et al.
Sci Rep
. 2024 Apr;
14(1):7709.
PMID: 38565882
The present study aimed at evaluating the YF-specific neutralizing antibody profile besides a multiparametric analysis of phenotypic/functional features of cell-mediated response elicited by the 1/5 fractional dose of 17DD-YF vaccine,...